• Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • 17-Ketosteroids, Urine
  • Antithrombin III
  • U3 RNP (Fibrillarin) Antibodies
  • Pyruvate, Spinal Fluid
  • Chromatin Antibody, IgG
  • Cold Agglutinin, Titer
  • Methamphetamine, Urine
  • Fibroblast Growth Factor 23 (FGF23), Plasma
  • Lactoferrin, Fecal
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Factor XIII (F13A1) V34L Genetic Variation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Factor XIII (F13A1) V34L Genetic Variation Analysis
Medical Test

Clinical Utility
Access to Factor XIII (F13A1) V34L Genetic Variation Analysis is restricted.
Loading...